Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

EW Relative to the S&P 500

EW Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Edwards Lifesciences Corp. (NYSE:EW) seasonal charts above shows that a Buy Date of November 30 and a Sell Date of April 24 has resulted in a geometric average return of 7.76% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 19 of those periods. This is an excellent rate of success and the return outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 1.88% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

To download EW seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: EW